C0005699 - An advanced phase of chronic myelogenous leukemia. It is characterized by: 1. the presence of blasts in the peripheral blood or bone marrow that are at least 20% of the peripheral blood white cells or of the nucleated cells in the bone marrow respectively, or 2. an extramedullary proliferation of blasts, and/or 3. when there are large aggregates and clusters of blasts in the bone marrow biopsy specimen (adapted from WHO, 2001). 1/10
home    UMLS 2020

293,031 терминов и синонимов из MeSH и LOINC

Поиск по CUI
Поиск по CODE


Поиск по одному или нескольким словам или частям слов
   


Lang   Dictionary       CODE         LUI      
preferred
no
       SUI   preference
Yes / No
Terms, descriptions
CUI    C0005699
RussianMedical Subject Headings Russian D001752 L3341393preferred S3868874 Y БЛАСТНЫЙ КРИЗ
RussianMedical Subject Headings Russian D001752 L0891280no S1095097 Y BLASTNYI KRIZ
RussianMDRRUS 10053747 L15780330no S19042780 N Кризис бластных клеток
RussianMDRRUS 10053747 L15780330no S19042780 Y Кризис бластных клеток
Medical Subject Headings A0031306 AT73506177 An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%.
Medical Subject Headings Czech A13040756 AT211597838 Pokročilá fáze chronické myeloidní leukemie vyznačující se rychlým nárůstem podílu nezralých bílých krvinek (blastů) v krvi a kostní dřeni. Hodnoty překračují až více než 30%.
NCI NCI Dictionary of Cancer Terms A17684340 AT197962452 A phase of chronic myelogenous leukemia in which 20% or more of the cells in the blood or bone marrow are blast cells (immature blood cells). When tiredness, fever, and an enlarged spleen occur during the blastic phase, it is called blast crisis.
NCI Thesaurus A17684340 AT198135547 An advanced phase of chronic myelogenous leukemia. It is characterized by: 1. the presence of blasts in the peripheral blood or bone marrow that are at least 20% of the peripheral blood white cells or of the nucleated cells in the bone marrow respectively, or 2. an extramedullary proliferation of blasts, and/or 3. when there are large aggregates and clusters of blasts in the bone marrow biopsy specimen (adapted from WHO, 2001).